Clinical Trial Update: Oxaliplatin in Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This update reports the completed Phase 2 trial of oxaliplatin in patients with unresectable hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED